Andres Correa, MD
Urology · Philadelphia, PANPI 1831410588
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Boston Scientific at 32.8% of the total. Reporting peaked in 2019 at $222 and has fallen 74.3% since, to $57 in 2025. That places this record below the midpoint for urology clinicians in PA, where the typical reported total is $2,187.
Across 14 payments — averaging $38.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$178
- Cook Medical LLC$88
- Neotract Inc.$72
- Ambu Inc.$62
- Urogen Pharma, Inc.$59
- AstraZeneca$35
- plus $49 from 3 others
Across 17 payments — averaging $12,976 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$221K
What the payments were for
- Food & beverage$50994%
- Education$356%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $178 |
| Cook Medical LLC | 1 | $88 |
| Neotract Inc. | 1 | $72 |
| Ambu Inc. | 2 | $62 |
| Urogen Pharma, Inc. | 3 | $59 |
| AstraZeneca | 1 | $35 |
| Merck | 1 | $22 |
| TELA Bio, Inc. | 1 | $14 |
| Coloplast | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$544 in reported general payments places this provider in the 25th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 141 | $1,693 |
| Finasteride | 101 | $1,294 |
| Oxybutynin Chloride ErOxybutynin Chloride | 48 | $822 |
| Testosterone | 12 | $738 |
| Trospium Chloride | 12 | $571 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $451 |
| Levofloxacin | 23 | $152 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $149 |
| Oxybutynin Chloride | 12 | $51 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $34 |
Paid to pharmacies, not to this prescriber.
Other urology in Philadelphia
- Demetrius BagleyPhiladelphia$739K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
- Paul ChungPhiladelphia$120K
- William JaffePhiladelphia$119K
- Robert UzzoPhiladelphia$111K
- Jay SimhanPhiladelphia$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.